Literature DB >> 18939938

Screening for hemochromatosis and iron overload: satisfaction with results notification and understanding of mailed results in unaffected participants of the HEIRS study.

Helen F Harrison1, Barbara W Harrison, Ann P Walker, Kurt Lohman, Shellie D Ellis, Mark A Hall, Jacob Reiss, Paul C Adams, Joan Holup, Ronald T Acton, Thomas Bent, Charles Rivers, Margaret Fadojutimi-Akinsiku.   

Abstract

AIM: The purpose of this study was to assess the level of satisfaction and understanding of test results, by a sample of non-C282Y homozygous participants in the hemochromatosis and iron overload screening (HEIRS) study, who received serum ferritin (SF), transferrin saturation (TS), and HFE gene test results by mail.
METHODS: Approximately 1 month after receiving test results by mail, participants were surveyed about understanding of and satisfaction with results notification.
RESULTS: Overall, participants were satisfied with receiving test results by mail. Participants receiving results with one or two HFE mutations or TS and/or SF levels outside the normal range (an "alert value") were less likely to be satisfied with this method of notification. Participants with normal HFE test results understood their results and recommendations better than those with one or two mutations. Although all participants received results letters in their native language, English-speaking participants had higher mean understanding scores than Mandarin, Vietnamese, or Spanish-speaking participants.
CONCLUSION: Participants were satisfied with receiving test results by mail. However, the level of understanding of the results was not sufficient for this mode of results notification to stand alone, especially for non-English speaking participants, and all participants with one or more test results outside the normal range.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18939938     DOI: 10.1089/gte.2008.0004

Source DB:  PubMed          Journal:  Genet Test        ISSN: 1090-6576


  9 in total

1.  Effect of ambiguous hemochromatosis gene test results on physician utilization.

Authors:  Mark Speechley; David Alter; Helen Guo; Helen Harrison; Paul C Adams
Journal:  Med Care       Date:  2012-05       Impact factor: 2.983

Review 2.  Ethical issues of predictive genetic testing for diabetes.

Authors:  Susanne B Haga
Journal:  J Diabetes Sci Technol       Date:  2009-07-01

3.  The Clinical Sequencing Evidence-Generating Research Consortium: Integrating Genomic Sequencing in Diverse and Medically Underserved Populations.

Authors:  Laura M Amendola; Jonathan S Berg; Carol R Horowitz; Frank Angelo; Jeannette T Bensen; Barbara B Biesecker; Leslie G Biesecker; Gregory M Cooper; Kelly East; Kelly Filipski; Stephanie M Fullerton; Bruce D Gelb; Katrina A B Goddard; Benyam Hailu; Ragan Hart; Kristen Hassmiller-Lich; Galen Joseph; Eimear E Kenny; Barbara A Koenig; Sara Knight; Pui-Yan Kwok; Katie L Lewis; Amy L McGuire; Mary E Norton; Jeffrey Ou; Donald W Parsons; Bradford C Powell; Neil Risch; Mimsie Robinson; Christine Rini; Sarah Scollon; Anne M Slavotinek; David L Veenstra; Melissa P Wasserstein; Benjamin S Wilfond; Lucia A Hindorff; Sharon E Plon; Gail P Jarvik
Journal:  Am J Hum Genet       Date:  2018-09-06       Impact factor: 11.025

4.  Impact of delivery models on understanding genomic risk for type 2 diabetes.

Authors:  S B Haga; W T Barry; R Mills; L Svetkey; S Suchindran; H F Willard; G S Ginsburg
Journal:  Public Health Genomics       Date:  2014-02-27       Impact factor: 2.000

5.  Potential nonresponse bias in a clinical examination after initial screening using iron phenotyping and HFE genotyping in the hemochromatosis and iron overload screening study.

Authors:  Mark Speechley; James C Barton; Leah Passmore; Helen Harrison; David M Reboussin; Emily L Harris; Charles A Rivers; Margaret Fadojutimi-Akinsiku; Lari Wenzel; Sharmin Diaz
Journal:  Genet Test Mol Biomarkers       Date:  2009-12

Review 6.  Screening for iron overload: lessons from the hemochromatosis and iron overload screening (HEIRS) study.

Authors:  Paul Adams; James C Barton; Gordon D McLaren; Ronald T Acton; Mark Speechley; Christine E McLaren; David M Reboussin; Catherine Leiendecker-Foster; Emily L Harris; Beverly M Snively; Thomas Vogt; Phyliss Sholinsky; Elizabeth Thomson; Fitzroy W Dawkins; Victor R Gordeuk; John H Eckfeldt
Journal:  Can J Gastroenterol       Date:  2009-11       Impact factor: 3.522

7.  Recommending inclusion of HFE C282Y homozygotes in the ACMG actionable gene list: cop-out or stealth move toward population screening?

Authors:  Anne-Marie Laberge
Journal:  Genet Med       Date:  2017-10-19       Impact factor: 8.822

8.  Genetic counseling and testing for Asian Americans: a systematic review.

Authors:  Jennifer L Young; Julie Mak; Talia Stanley; Michelle Bass; Mildred K Cho; Holly K Tabor
Journal:  Genet Med       Date:  2021-05-10       Impact factor: 8.822

9.  Delivering pharmacogenetic testing in a primary care setting.

Authors:  Rachel Mills; Deepak Voora; Bruce Peyser; Susanne B Haga
Journal:  Pharmgenomics Pers Med       Date:  2013-09-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.